We are very pleased to invite you to the Second Edition of the French Event hold on the occasion of
BIO. The “Fast-Track R&D Partnering with France - 2” will be a real opportunity for you to :
 Network with French and International Biotech Companies. A dedicated time for Networking
and the Big Party will allow you to meet and partner with more than 100 expected companies
 Experience fast-tracker way to speed-up your R&D project by partnering with France. The
event will include presentations, discussions and Q&A to show you how relevant it is on gathering
partnerships and building a biocluster critical mass.
The event will start at 3.00pm on Monday 16th June, at the W San Diego hotel.
The registration will open on May 15th by login to the web platform : www.FTRD2-BIO2008.com
Please find hereafter the program.
PROGRAM
(subject to modification)
Moderator : Patrick Tricoli, Senior Director, Partnering & Innovation, sanofi-aventis
2.30 pm
Registration open
3.00 pm
Welcome Address
His excellency Pierre Vimont, Ambassador of France in United States
The honorable Philippe Larrieu, Consul General of France in Los Angeles
3.20 pm
Opening
What are the Key Success Factors for Biotechnology and a Key Player like
Amgen to Develop in France ?
Marc de GARIDEL, VP South Region International Commercial Operations, AMGEN
3.40 pm
How Relevant is it on Gathering Partnerships and Building a Biocluster Critical
Mass?
 Experience the Following Developments
PHENOPRO: From Academic Phenotyping Spinout to International Industrial
Partnership
Frédéric Allemand, MD, Head of Operations and Corporate Development, PhenoPro
SAS
San Phelan, Chairman, Taconic Farms
EBx®: a New Cell Platform for the Biomanufacturing of Monoclonal Antibodies
Dr Pierre Miniou, Licensing & Business Development, Vivalis
MEDUL: New Hope for Spinal Cord Injury Patients
Pascal Deschaseaux, MD, MBA, CEO, Pharmaxon
IgA: an Investigation in the Therapeutic Potential of Monoclonal IgA
Eric Perouzel, Business Development Manager, InvivoGen Therapeutics
DEMINAP: Use of Toll-like Receptors to Detect Unapparent Micro-Organisms
for Diagnostic and Therapeutic Applications
Yannis Morel, Director, Business Development, Innate Pharma
PREDICAN : An Innovative Screening Method for Mutations Detection
Nicolas Guyot, CEO, FLUIGENT
IT-Diab : Innovative Therapy – Diabetes
Jean François MOUNEY, Chairman and CEO, GENFIT
5.30 to 6.00 pm
Key Note : American Companies from San Diego supporting French BIO Beach
 Introduction by Stephane Richard, Staff Scientist at the Salk Institute for
Biological Studies, Founder of Gen2X and French BIO Beach

Claude Benchimol, Senior Vice-President, Research & Development,
INVITROGEN Corporation

Alan Carter,
Genomics
Senior
Vice-President,
Business
Development,
CODA
6.00 to 6.30 pm
Closing
How does a Global Pharmaceutical Industry Develop their Partnerships with
France?
 The point of view of sanofi pasteur
Luc Aujame, Director, External R&D, sanofi pasteur
6.30 to 7.15 pm
Speedy Networking and Meeting Corner
 To meet potential partners and exchange with major biotech business actors
07.30 to 9.00 pm
The Big Party
 To continue your networking